An Australian tuberous sclerosis cohort: Are surveillance guidelines being met?

被引:19
作者
Chopra, Maya [1 ,2 ,3 ,4 ]
Lawson, John A. [1 ,2 ]
Wilson, Meredith [3 ,4 ]
Kennedy, Sean E. [1 ]
Taylor, Peter [5 ]
Buckley, Michael F. [5 ]
Wargon, Orli [1 ]
Parasivam, Gayathri [1 ]
Camphausen, Christoph [1 ,2 ]
Yates, Deborah [6 ]
Mowat, David [1 ,2 ]
机构
[1] Sydney Childrens Hosp, Tuberous Sclerosis Multidisciplinary Management C, Randwick, NSW 2031, Australia
[2] Univ New S Wales, Sch Women & Childrens Hlth, Sydney, NSW, Australia
[3] Univ Sydney, Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2006, Australia
[4] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia
[5] S Eastern Area Lab Serv, Mol & Cytogenet Unit, Dept Haematol & Genet, Sydney, NSW, Australia
[6] St Vincents Hosp, Dept Thorac Med, Darlinghurst, NSW 2010, Australia
关键词
TSC surveillance; TSC1; mutation; TSC2; tuberous sclerosis complex; GIANT-CELL ASTROCYTOMAS; CONSENSUS CONFERENCE; MUTATIONAL ANALYSIS; COMPLEX; TSC1; LYMPHANGIOLEIOMYOMATOSIS; EMBOLIZATION; REGRESSION; PHENOTYPE; RAPAMYCIN;
D O I
10.1111/j.1440-1754.2011.02038.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: This study aims to describe the phenotypic and genotypic characteristics of 45 Australian patients with tuberous sclerosis complex (TSC), to assess risk factors for intellectual disability, to compare patients with TSC1 and TSC2 mutations and to assess adherence to surveillance recommendations. Methods: Phenotypic features were recorded in 45 patients who fulfilled established criteria for a diagnosis of definite TSC. All patients underwent TSC1 and TSC2 sequencing and multiplex ligand probe amplification. Features were compared in patients with TSC1 mutations versus TSC2 mutations. Recent surveillance was recorded at the point of first contact. Surveillance adherence was compared in the adult and paediatric cohorts. Results: This cohort consisted of 31 children and 14 adults with definite TSC. The rates of TSC manifestations and TSC1 and TSC2 mutation detection rates were consistent with previous studies. There was a trend towards greater severity for patients with TSC2 mutations compared with their TSC1 counterparts, particularly for autistic spectrum disorder, but this did not reach statistical significance. The presence of seizures was shown to be a risk factor for intellectual disability (P < 0.001). Overall, 12/45 patients (27%) were not undergoing recommended surveillance at the point of first contact. Surveillance guidelines were being followed in 3/31 (11%) children compared with 9/14 (64%) adult patients (P < 0.05). Conclusions: The genotypic and phenotypic characteristics of this TSC cohort were consistent with previous studies. Surveillance rates in adult patients were significantly lower than in paediatric patients. This highlights the need for patients with TSC to undergo a focussed transition into adult services.
引用
收藏
页码:711 / 716
页数:6
相关论文
共 26 条
[1]   Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States [J].
An, Kit Sing ;
Williams, Aimee T. ;
Roach, E. Steve ;
Batchelor, Lori ;
Sparagana, Steven P. ;
Delgado, Mauricio R. ;
Wheless, James W. ;
Baumgartner, James E. ;
Roa, Benjamin B. ;
Wilson, Carolyn M. ;
Smith-Knuppel, Teresa K. ;
Cheung, Min-Yuen C. ;
Whittemore, Vicky H. ;
King, Terri M. ;
Northrup, Hope .
GENETICS IN MEDICINE, 2007, 9 (02) :88-100
[2]   Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis [J].
Bissler, John J. ;
McCormack, Francis X. ;
Young, Lisa R. ;
Elwing, Jean M. ;
Chuck, Gail ;
Leonard, Jennifer M. ;
Schmithorst, Vincent J. ;
Laor, Tal ;
Brody, Alan S. ;
Bean, Judy ;
Salisbury, Shelia ;
Franz, David N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02) :140-151
[3]   Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs [J].
Dabora, SL ;
Jozwiak, S ;
Franz, DN ;
Roberts, PS ;
Nieto, A ;
Chung, J ;
Choy, YS ;
Reeve, MP ;
Thiele, E ;
Egelhoff, JC ;
Kasprzyk-Obara, J ;
Domanska-Pakiela, D ;
Kwiatkowski, DJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (01) :64-80
[4]   Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex [J].
Ewalt, DH ;
Diamond, N ;
Rees, C ;
Sparagana, SP ;
Delgado, M ;
Batchelor, L ;
Roach, ES .
JOURNAL OF UROLOGY, 2005, 174 (05) :1764-1766
[5]  
Franz DN, 2009, ARCH DIS CHILD, V94, P75
[6]   Rapamycin causes regression of astrocytomas in tuberous sclerosis complex [J].
Franz, DN ;
Leonard, J ;
Tudor, C ;
Chuck, G ;
Care, M ;
Sethuraman, G ;
Dinopoulos, A ;
Thomas, G ;
Crone, KR .
ANNALS OF NEUROLOGY, 2006, 59 (03) :490-498
[7]   Lymphangioleiomyomatosis: a review of the literature [J].
Hancock, E ;
Osborne, J .
RESPIRATORY MEDICINE, 2002, 96 (01) :1-6
[8]   European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis [J].
Johnson, S. R. ;
Cordier, J. F. ;
Lazor, R. ;
Cottin, V. ;
Costabel, U. ;
Harari, S. ;
Reynaud-Gaubert, M. ;
Boehler, A. ;
Brauner, M. ;
Popper, H. ;
Bonetti, F. ;
Kingswood, C. .
EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (01) :14-26
[9]   Lymphangioleiomyomatiosis [J].
Johnson, SR .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (05) :1056-1065
[10]   Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis [J].
Jones, AC ;
Daniells, CE ;
Snell, RG ;
Tachataki, M ;
Idziaszczyk, SA ;
Krawczak, M ;
Sampson, JR ;
Cheadle, JP .
HUMAN MOLECULAR GENETICS, 1997, 6 (12) :2155-2161